Table 1.
Demographics of MS Patient Group Compared to Controls
| Demographics | MS | Controls |
|---|---|---|
| Females: Males (% Female) | 371:153 (70.8%) | 192:112 (63.3%)a |
| Disease course | ||
| Relapsing remitting | 348 (66.4%) | |
| Secondary progressive | 139 (26.5%) | |
| Primary progressive | 37 (7.1%) | |
| Race/ethnicity (%)b | ||
| Caucasian | 486 (93.1%) | 261 (87.0%) |
| African American | 22 (4.2%) | 23 (7.7%) |
| Hispanic Latino | 9 (1.7%) | 3 (1.0%) |
| Asian | 2 (0.4%) | 10 (3.3%) |
| Other | 3 (0.5%) | 0 (0%) |
| Age, years | 47.6 ± 11.1 | 45.9 ± 15.1 |
| Disease duration, years | 15.2 ± 10.5 | |
| Treatment duration, years | 4.32 ± 3.88 | |
| Median EDSS (IQR) | 3.0 (4.0) | |
a
Males include two transgender males.
b
Race data were missing for four HC and two MS patients.
HC, healthy controls; MS, multiple sclerosis.